Louis Scafuri
Chief Executive Officer
Claimed by owner Sofwave
Former names: ArchimedUS Medical
Noninvasive Ultrasound Technology for Reducing Wrinkles
Public on TASE May, 2021
Sofwave
www.globenewswire.com
•
Mar 15, 2023
Sofwave™ Granted FDA Clearance For Latest Innovation: The "Precise" SUPERB™ Applicator
www.globenewswire.com
•
Dec 19, 2022
Sofwave Medical Announces FDA Clearance of SUPERB™ Technology For Cellulite
www.globenewswire.com
•
Oct 18, 2022
Sofwave™ Granted U.S. Patent Covering Key Elements of the Company's Proprietary SUPERB™ Non-Surgical Skin and Collagen Remodeling Technology
www.globenewswire.com
•
Aug 25, 2022
Sofwave™ to Showcase SUPERB™ (Synchronous Ultrasound Parallel Beam Technology) Live and In-Person at 5CC International Aesthetic Medical and Dermatology Conference
www.globenewswire.com
•
Aug 16, 2022
Sofwave Medical Reports First Half Financial Results and Business Highlights
www.globenewswire.com
•
Aug 9, 2022
Key Collaboration and Distribution Agreement Signed With Major Partner To Advance Sofwave™ Sales In China's Growing $29 Billion Aesthetic Medicine Market
www.prnewswire.co.uk
•
May 16, 2022
SOFWAVE™ TECHNOLOGY WINS MAJOR BEAUTY AWARDS -- 2022 ADDING TO THE 2021 ELLE AWARD
www.prnewswire.com
•
Mar 9, 2022
Sofwave Medical LTD reports financial results for the full year 2021 with accelerated growth in revenues and gross margin
www.prnewswire.com
•
Dec 13, 2021
Sofwave™ Awarded Elle Magazine's 2021 Future of Beauty Awards!
www.newswire.ca
•
Nov 16, 2021
Sofwave™ Announces FDA clearance of New Lifting Indications for Eyebrow, Sub-Mental (beneath the chin) and Neck Facial Areas
www.prnewswire.com
•
Jun 3, 2021
https://www.prnewswire.com/in/news-releases/sofwave-tm-medical-raises-50m-and-completes-initial-public-offering-on-the-tel-aviv-stock-exchange-839873136.html
www.prnewswire.com
•
Jun 3, 2021
Sofwave™ Medical Raises $50M and Completes Initial Public Offering on the Tel Aviv Stock Exchange
www.calcalist.co.il
•
May 13, 2021
סופווייב נהנתה מביקושים של יותר מפי שניים; תתחיל להיסחר בתל אביב בשבוע הבא כלכליסט
www.themarker.com
•
May 13, 2021
סופווייב מדיקל הונפקה בתל אביב - וגייסה 50 מיליון דולר
en.globes.co.il
•
Apr 19, 2021
Skin treatment co Sofwave files to raise $50m on TASE
www.prnewswire.com
•
Mar 10, 2021
Sofwave Receives Australian Regulatory Approval to Market SUPERB™, the Breakthrough Ultrasound Technology Treating Fine Lines & Wrinkles
en.globes.co.il
•
Feb 16, 2021
Skin treatment co Sofwave plans TASE IPO
www.prnewswire.com
•
Nov 16, 2020
Sofwave receives CE Medical Mark and additional key Regulatory Clearances for its Revolutionary Skin Tightening and Wrinkle Reduction Device
www.prnewswire.com
•
Aug 5, 2020
First Two Doctors in Arizona to Offer Sofwave™ Newest Non-invasive Treatment to Hit the Market for Fine Lines and Wrinkles on Face & Neck
www.prnewswire.com
•
Jul 8, 2020
Arielle Kauvar, M.D., Announces New Technology to Improve Fine Lines and Wrinkles on the Face and Neck with Successful Clinical Study Pivotal to Sofwave's™ FDA 510K Clearance.
www.prnewswire.com
•
Sep 16, 2019
SofWave Medical's Low-divergence Ultrasound Technology Has Received FDA Clearance for the Aesthetic Treatment of Facial Lines and Wrinkles
en.globes.co.il
•
Aug 6, 2019
Skin tightening cosmetic co SofWave Medical raises $8.4m
About
Sofwave is the developer of synchronous ultrasound parallel beam (SUPERB) technology, in which ultrasound energy passes precisely through the epidermis (the skin’s surface layer) and heats the mid-dermal tissue at the exact depth and temperature to rejuvenate collagen fibers and improve the overall appearance of the skin.
Sofwave is FDA cleared and clinically proven to remodel collagen, which improves facial lines and wrinkles and lifts the eyebrows, submental, and neck area. The technology is comfortably delivered with minimal downtime in a single 30- to 45-minute treatment, regardless of skin type.
Sofwave is FDA cleared and clinically proven to remodel collagen, which improves facial lines and wrinkles and lifts the eyebrows, submental, and neck area. The technology is comfortably delivered with minimal downtime in a single 30- to 45-minute treatment, regardless of skin type.
Primary Sector
Life Sciences & HealthTech
Products
SuperB
Geographic markets
North America, Africa, Eastern Europe, Middle Africa, Global, West Asia, Southern Africa, Northern Africa, Oceania, Americas, Europe, Southern Europe, Northern Europe, Central Asia, North Asia, Southeast Asia, South America, Western Europe, Asia, Central America, South Asia, East Asia
Funding
Total Funding
$58.4M
Market Cap
$85.6M
Last Funding
$50M
Funding Stage
Total Rounds
2
Investors
3
News
(22)
www.globenewswire.com
•
Mar 15, 2023
Sofwave™ Granted FDA Clearance For Latest Innovation: The "Precise" SUPERB™ Applicator
www.globenewswire.com
•
Dec 19, 2022
Sofwave Medical Announces FDA Clearance of SUPERB™ Technology For Cellulite
www.globenewswire.com
•
Oct 18, 2022
Sofwave™ Granted U.S. Patent Covering Key Elements of the Company's Proprietary SUPERB™ Non-Surgical Skin and Collagen Remodeling Technology
www.globenewswire.com
•
Aug 25, 2022
Sofwave™ to Showcase SUPERB™ (Synchronous Ultrasound Parallel Beam Technology) Live and In-Person at 5CC International Aesthetic Medical and Dermatology Conference
www.globenewswire.com
•
Aug 16, 2022
Sofwave Medical Reports First Half Financial Results and Business Highlights
www.globenewswire.com
•
Aug 9, 2022
Key Collaboration and Distribution Agreement Signed With Major Partner To Advance Sofwave™ Sales In China's Growing $29 Billion Aesthetic Medicine Market
www.prnewswire.co.uk
•
May 16, 2022
SOFWAVE™ TECHNOLOGY WINS MAJOR BEAUTY AWARDS -- 2022 ADDING TO THE 2021 ELLE AWARD
www.prnewswire.com
•
Mar 9, 2022
Sofwave Medical LTD reports financial results for the full year 2021 with accelerated growth in revenues and gross margin
www.prnewswire.com
•
Dec 13, 2021
Sofwave™ Awarded Elle Magazine's 2021 Future of Beauty Awards!
www.newswire.ca
•
Nov 16, 2021
Sofwave™ Announces FDA clearance of New Lifting Indications for Eyebrow, Sub-Mental (beneath the chin) and Neck Facial Areas
www.prnewswire.com
•
Jun 3, 2021
https://www.prnewswire.com/in/news-releases/sofwave-tm-medical-raises-50m-and-completes-initial-public-offering-on-the-tel-aviv-stock-exchange-839873136.html
www.prnewswire.com
•
Jun 3, 2021
Sofwave™ Medical Raises $50M and Completes Initial Public Offering on the Tel Aviv Stock Exchange
www.calcalist.co.il
•
May 13, 2021
סופווייב נהנתה מביקושים של יותר מפי שניים; תתחיל להיסחר בתל אביב בשבוע הבא כלכליסט
www.themarker.com
•
May 13, 2021
סופווייב מדיקל הונפקה בתל אביב - וגייסה 50 מיליון דולר
en.globes.co.il
•
Apr 19, 2021
Skin treatment co Sofwave files to raise $50m on TASE
www.prnewswire.com
•
Mar 10, 2021
Sofwave Receives Australian Regulatory Approval to Market SUPERB™, the Breakthrough Ultrasound Technology Treating Fine Lines & Wrinkles
en.globes.co.il
•
Feb 16, 2021
Skin treatment co Sofwave plans TASE IPO
www.prnewswire.com
•
Nov 16, 2020
Sofwave receives CE Medical Mark and additional key Regulatory Clearances for its Revolutionary Skin Tightening and Wrinkle Reduction Device
www.prnewswire.com
•
Aug 5, 2020
First Two Doctors in Arizona to Offer Sofwave™ Newest Non-invasive Treatment to Hit the Market for Fine Lines and Wrinkles on Face & Neck
www.prnewswire.com
•
Jul 8, 2020
Arielle Kauvar, M.D., Announces New Technology to Improve Fine Lines and Wrinkles on the Face and Neck with Successful Clinical Study Pivotal to Sofwave's™ FDA 510K Clearance.
www.prnewswire.com
•
Sep 16, 2019
SofWave Medical's Low-divergence Ultrasound Technology Has Received FDA Clearance for the Aesthetic Treatment of Facial Lines and Wrinkles
en.globes.co.il
•
Aug 6, 2019
Skin tightening cosmetic co SofWave Medical raises $8.4m
The Team
(5)
LS
SE
Shimon Eckhouse
Co-founder
AS
Ariel Sverdlik
Co-founder & CTO
Genady Nahshon
Co-founder , COO & Site Manager
BG
Bella Gitnik
SEO & PPC Manager
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Public Offerings & Exits
Initial Public Offering
EXIT
$50M
May 2021
Stock Exchange
TASE
Valuation
$245M
$50M
Private Equity Funding
Undisclosed Round
$8.4M
Aug 2019
3 Investors
$8.4M
Media gallery
(3)
Sofwave Device
Sofwave Treatment
Locations
Israel
Yokneam Illit, Israel
Offices Abroad
New York, NY, USA
14331 Chambers Road, Tustin, California 92780, USA
Locations
Israel
Yokneam Illit, Israel
Offices Abroad
New York, NY, USA
14331 Chambers Road, Tustin, California 92780, USA
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,